Testing effectiveness (Phase 2)Study completedNCT01593761
What this trial is testing
Phase 2a Study of CG400549 for the Treatment of cABSSSI Caused by Methicillin-resistant Staphylococcus Aureus
Who this might be right for
Skin Infection
CrystalGenomics, Inc. 20